Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 166.00
Open 165.00
Day range 163.80 167.00
52-week range 117.60 192.20
Off day high −1.92%
Off 52-week high −14.78%
Volume 25.45K
Avg. volume (3M) 24.91K
Market cap 3.91B
EPS (TTM) 5.41
Forward P/E 19.93
P/E ratio (TTM) 30.28
Dividend yield 1.66% (2.75)
Beta (5Y) 0.92
Shares outstanding 23.85M
Short interest —
Earnings date Oct 29, 2026
Analyst target 181.67
Profit margin 17.47%
No recent coverage in the 4Search index.
From articles in the 4Search news index.
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; an…
Sector Healthcare
Industry Medical Devices
Chief executive Steve Ferguson
Employees 251
Headquarters Lund, Sweden
Buy 3 analysts
0 2 1 0 0 12-month price target 181.67 +10.91%
Low 160.00 Current 163.80 High 200.00
Wall Street analyst consensus. Not a recommendation.
Earnings
Next report: Thu, Oct 29, 2026
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use .